amrinone and rolipram

amrinone has been researched along with rolipram in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19902 (16.67)18.7374
1990's6 (50.00)18.2507
2000's3 (25.00)29.6817
2010's1 (8.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bristol, JA; Cain, MH; Weishaar, RE1
Kasugai, S; Miyamoto, K; Ohya, K; Sawanishi, H; Suzuki, H; Suzuki, N; Takagi, K; Waki, Y; Yamamoto, S1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Chiba, S; Horiuchi, A; Iwatsuki, K; Ren, LM1
Weiss, RM; Wheeler, MA1
Azizeh, BY; Houslay, MD; Hruby, VJ; Johnson, DG; Phelps, JR; Trivedi, D; Van Tine, BA1
Haskó, G; Németh, ZH; Salzman, AL; Szabó, C; Vizi, ES1
Arner, P; Degerman, E; Enoksson, S; Hagström-Toft, E; Large, V1
Sawada, M; Suzumura, A; Takayanagi, T; Tamaru, T; Yoshikawa, M1
Sadan, G; Usta, C1
Deschl, U; Platz, SJ; Schleger, C1
Norton, G; Osadchii, O; Woodiwiss, A1

Reviews

1 review(s) available for amrinone and rolipram

ArticleYear
A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity.
    Journal of medicinal chemistry, 1985, Volume: 28, Issue:5

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Blood Platelets; Calmodulin; Cardiotonic Agents; Guinea Pigs; Humans; Hypersensitivity; In Vitro Techniques; Lung Diseases; Myocardium; Platelet Aggregation; Substrate Specificity

1985

Other Studies

11 other study(ies) available for amrinone and rolipram

ArticleYear
Selective inhibitors of cyclic AMP-specific phosphodiesterase: heterocycle-condensed purines.
    Journal of medicinal chemistry, 1997, Sep-26, Volume: 40, Issue:20

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Oral; Animals; Cyclic Nucleotide Phosphodiesterases, Type 4; Depression, Chemical; Heart; Isoenzymes; Male; Models, Chemical; Muscle Relaxation; Myocardium; Phosphodiesterase Inhibitors; Purines; Shrews; Trachea

1997
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Effects of the cyclic nucleotide phosphodiesterase inhibitors, rolipram, 3-isobutyl-1-methylxanthine, amrinone and zaprinast, on pancreatic exocrine secretion in dogs.
    European journal of pharmacology, 1991, Dec-10, Volume: 209, Issue:1-2

    Topics: 1-Methyl-3-isobutylxanthine; 2',3'-Cyclic-Nucleotide Phosphodiesterases; Amrinone; Animals; Bicarbonates; Cyclic AMP; Cyclic GMP; Dogs; Female; Male; Pancreas; Pancreatic Juice; Perfusion; Phosphodiesterase Inhibitors; Proteins; Purinones; Pyrrolidinones; Rolipram; Secretin; Sincalide

1991
Insulin activation of cyclic AMP phosphodiesterase in intact ureteral segments.
    The Journal of pharmacology and experimental therapeutics, 1988, Volume: 247, Issue:2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Amrinone; Animals; Cyclic GMP; Enzyme Activation; Female; Guinea Pigs; Insulin; Kinetics; Milrinone; Purinones; Pyridones; Pyrrolidinones; Rolipram; Ureter

1988
Low level cyclic adenosine 3',5'-monophosphate accumulation analysis of [des-His1, des- Phe6, Glu9] glucagon-NH2 identifies glucagon antagonists from weak partial agonists/antagonists.
    Endocrinology, 1996, Volume: 137, Issue:8

    Topics: 1-Methyl-3-isobutylxanthine; Adenylyl Cyclase Inhibitors; Amrinone; Animals; Blood Glucose; Cyclic AMP; Diabetes Mellitus, Experimental; Glucagon; Liver; Male; Phosphodiesterase Inhibitors; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Rolipram

1996
Suppression of IL-12 production by phosphodiesterase inhibition in murine endotoxemia is IL-10 independent.
    European journal of immunology, 1998, Volume: 28, Issue:2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Amrinone; Animals; Cyclic Nucleotide Phosphodiesterases, Type 4; Endotoxemia; Injections, Intraperitoneal; Interferon-gamma; Interleukin-10; Interleukin-12; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Pyrrolidinones; Rolipram; Tumor Necrosis Factor-alpha

1998
Various phosphodiesterase subtypes mediate the in vivo antilipolytic effect of insulin on adipose tissue and skeletal muscle in man.
    Diabetologia, 1998, Volume: 41, Issue:5

    Topics: Adipose Tissue; Adult; Aged; Aged, 80 and over; Amrinone; Blood Glucose; Dialysis Solutions; Dipyridamole; Ethanol; Female; Glycerol; Humans; Hypoglycemic Agents; Insulin; Isoenzymes; Lipolysis; Male; Middle Aged; Muscle, Skeletal; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrrolidinones; Regional Blood Flow; Rolipram; Sterol Esterase; Theophylline; Vasodilator Agents

1998
Effects of phosphodiesterase inhibitors on cytokine production by microglia.
    Multiple sclerosis (Houndmills, Basingstoke, England), 1999, Volume: 5, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; Amrinone; Animals; Anti-Ulcer Agents; Cilostazol; Colforsin; Dipyridamole; DNA Primers; Gene Expression Regulation, Enzymologic; Interleukin-1; Interleukin-6; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Papaverine; Pentoxifylline; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrazines; Pyrrolidinones; Quinolines; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Rolipram; Tetrazoles; Theophylline; Tumor Necrosis Factor-alpha; Vinca Alkaloids; Xanthines

1999
Comparison of the effects of selective III, IV and nonselective phosphodiesterase inhibitors on isolated tracheal preparations in streptozotocin-diabetic rats.
    Pharmacology, 2000, Volume: 60, Issue:1

    Topics: Amrinone; Animals; Carbachol; Cardiotonic Agents; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Male; Muscle Contraction; Muscle Relaxation; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Rolipram; Streptozocin; Theophylline; Trachea

2000
Development of an in vitro model for vascular injury with human endothelial cells.
    ALTEX, 2004, Volume: 21 Suppl 3

    Topics: 3T3 Cells; Amrinone; Animal Testing Alternatives; Animals; Antibiotics, Antineoplastic; Antifibrinolytic Agents; Cell Membrane Permeability; Cell Survival; Cells, Cultured; Cyclosporine; Dose-Response Relationship, Drug; Electric Impedance; Endothelial Cells; Endothelium, Vascular; Epoprostenol; Humans; Immunosuppressive Agents; Injections, Intravenous; Mice; Mitomycin; Models, Biological; Phosphodiesterase Inhibitors; Rolipram; Thromboxane A2; Umbilical Veins; Vitamin K 3

2004
Inotropic responses to phosphodiesterase inhibitors in cardiac hypertrophy in rats.
    European journal of pharmacology, 2005, May-09, Volume: 514, Issue:2-3

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Amrinone; Animals; Blood Pressure; Cardiomegaly; Cardiotonic Agents; Dose-Response Relationship, Drug; Heart; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Myocardium; Organ Size; Pentoxifylline; Phosphodiesterase Inhibitors; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rolipram

2005